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Abstract 19 
Objectives 20 
To utilise a large database available from a UK-based, commercial veterinary diagnostic 21 
laboratory to ascertain the prevalence of different forms of cutaneous neoplasia within the 22 
feline population, and to detect any breed, sex, or age predilections for the more common 23 
tumours. 24 
  25 
Methods 26 
Records from the laboratory were searched for feline submissions received between the dates 27 
31st May 2006 and 31st October 2013. For masses arising within the skin for which 28 
histopathology had been performed, the diagnosis was recorded together with the breed, age, 29 
sex and neuter status of the cat. Odds ratios for breed predisposition to skin tumours overall, to 30 
histologically malignant tumours and to the more commonly occurring tumours were 31 
calculated, with the non-pedigree cat population as the control. 32 
 33 
Results 34 
Of the 219,083 feline samples submitted, masses arising within the skin comprised 4.4% and 35 
there were 89 different diagnoses recorded for these masses. Just 6.6% of these cases were non-36 
neoplastic in nature, and of neoplastic masses, 52.7% were considered histologically malignant. 37 
The ten most common skin tumour types accounted for 80.7% of cases, with the four most 38 
common being basal cell tumours, fibrosarcomas, squamous cell carcinoma and mast cell 39 
tumours.  40 
 41 
Conclusions and relevance 42 
Despite the large number of different diagnoses in this study, a relatively small number of 43 
tumour types accounts for the majority of skin masses in occurring cats, most of which are 44 
neoplastic in nature. There are a number of breed predispositions for the more common tumour 45 
types, although no pedigree breed had increased odds of developing a malignant tumour 46 
compared to the non-pedigree cat population; several breeds had significantly decreased odds. 47 
Just over half of the neoplastic masses in this study were considered histologically malignant.  48 
 49 
 50 
Introduction 51 
The skin and subcutis are the most common anatomic locations for tumours to arise in the cat.1 52 
As both the largest and the most exposed organ of the body, the skin is particularly susceptible 53 
to external insults in a variety of forms, and it is also the most easily visualised and palpable. 54 
Whilst there have been several major studies regarding the prevalence of feline tumours in 55 
other countries, including both the USA and Switzerland,2,3 there is little current information 56 
available as to the prevalence of cutaneous tumours specific to the UK cat population.   57 
 58 
There is some variation between these studies, but the general consensus is that the four most 59 
common skin tumour types are fibrosarcoma, squamous cell carcinoma, mast cell tumour and 60 
the tumours which fall under the umbrella term of ‘basal cell tumour’,2,3,4,5 with some 61 
differences in the order of prevalence depending on the particular study. 62 
 63 
The purpose of this study was to utilise a large data set from a commercial veterinary diagnostic 64 
laboratory to determine the prevalence of different forms of cutaneous tumours in the UK cat 65 
population, during the period from 31st May 2006 to the 31st October 2013, and to detect any 66 
breed, sex, or age predilections for the more common tumours.   67 
 68 
Material and Methods 69 
Records from a large, UK-based commercial diagnostic laboratory (Finn Pathologists, Diss, 70 
UK) were searched for feline submissions received between the dates 31st May 2006 and 31st 71 
October 2013, including samples submitted for various blood tests, cytology and 72 
histopathology. Histopathology samples taken from masses arising within the skin were then 73 
searched for according to the diagnosis made by the histopathologist originally reporting the 74 
case. Masses submitted from cats based outside of the UK, or any tumour not located within 75 
the epidermis, dermis, subcutis or skin appendages were excluded. Tumours arising from the 76 
mammary glands, oral cavity and third eyelid were also excluded, while tumours arising from 77 
the ears and anal gland region were included for the purposes of this study. Cats with multiple 78 
samples taken from the same tumour were recorded only once. For all cases included in this 79 
study the breed, age and sex and neuter status of the cat were recorded, where this data was 80 
available from the original submission form, as well as the histopathological diagnosis of the 81 
mass.   82 
 83 
A total of 35 different feline breeds were recorded. Domestic shorthair (DSH), Domestic 84 
longhair (DLH), Domestic cat and ‘crossbreed’ cats were amalgamated under the term ‘non-85 
pedigree’, and cats of unspecified breed were recorded as ‘unknown’. Cats classified as non-86 
pedigree were used as the standard for comparison both for determining whether pedigree 87 
breeds had a statistically significant different odds ratio with regard to developing skin tumours 88 
and the odds of having a malignant tumour. Gender was recorded as one of the following: male, 89 
male neutered, female, female neutered, unknown.  90 
 91 
Cutaneous masses were classified into either neoplastic or non-neoplastic (including cysts, 92 
hamartomas, inflammatory, hyperplastic or pigmentary growths forming a mass-type lesion). 93 
Masses were then further categorised into one of four groups based upon their embryological 94 
origin; epithelial, mesenchymal, melanocytic or haematopoietic. Any remaining neoplasms 95 
which were either metastatic tumours or did not fit these categories and any skin tumours of 96 
indeterminable origin were classified as metastatic/other. The term ‘basal cell tumour’ was 97 
used to encompass all forms of benign basal cell tumour, including trichoblastomas and 98 
apocrine ductal adenomas. 99 
 100 
Statistical analysis was performed using Prism 7 for Mac OS X (Version 7.0a). Data were 101 
systematically tested for normality and tested accordingly with D’Agostino and Pearson 102 
normality or Kruskall-Wallis tests as appropriate. Odds ratios for breed predisposition to skin 103 
tumours, malignant tumours and certain types of tumours were calculated using an odds ratio 104 
calculator (MedCalc®,Version 16.8.4) at a 95% confidence interval with non-pedigree (OR = 105 
1) as the control against which all other breeds were assessed. A p value less than 0.05 was 106 
considered to be significant.   107 
 108 
Results 109 
The total number of feline submissions to the laboratory over the time period 31st May 2006 to 110 
31st October 2013 was 219,083, including blood samples, cytology and histopathology 111 
submissions. Of these, masses arising within the skin comprised 4.4% (9,683) affecting a total 112 
of 9,200 individual cats, and for which there were 89 different diagnoses recorded. Of these 113 
skin masses, 6.6% (636 of the 9,683) were non-neoplastic in nature; the three most common 114 
diagnoses were follicular cysts (307 cases), apocrine gland cysts (178 cases) and dermoid cysts 115 
(44 cases), accounting for 83% of all the non-neoplastic masses in this study.  116 
 117 
The remaining masses were deemed neoplastic in nature (9,047 of the 9,683; 93.4%), with 118 
47.6% of these categorised as benign and 52.7% as malignant based on the original 119 
histopathology report (the remaining five masses could not be clearly categorised as either 120 
benign or malignant). 121 
 122 
For the benign cutaneous neoplasms, those of epithelial origin were the most frequent subtype, 123 
accounting for 66% of all benign tumours in this study (2,823 out of 4,275 masses), followed 124 
by tumours of mesenchymal origin (17.5%; 748 out of 4,275 masses), tumours of 125 
haematopoietic origin (15.0%; 642 out of 4,275) and tumours of melanocytic origin (1.5%; 62 126 
out of 4,275). For malignant neoplasms, tumours of mesenchymal origin were most common 127 
subtype comprising 49% of all malignant cutaneous masses (2,342 out of 4,767 masses), 128 
followed closely by those of epithelial origin (39.4%, 1,877 out of 4,767). Metastatic and other 129 
tumours accounted for 8% (381 of 4,767) and the remainder were of melanocytic (2.2%, 107 130 
from 4,767) or haematopoietic origin (1.3%, 60 out of 4,767; table 1). 131 
   132 
Breed 133 
Cats classified as non-pedigree (including DSH, DLH, “domestic cat” and “crossbreed”) 134 
accounted for 88.2% of all feline sample submissions to the laboratory, while cats with no 135 
breed recorded (“unclassified”) accounted for 3%, and the remainder of the cat population (9%) 136 
comprised various pedigree breeds.  137 
 138 
When considering all cutaneous neoplasms, both benign and malignant, certain breeds had 139 
statistically significant increased odds of developing a skin tumour when compared to the non-140 
pedigree cat population (figure 1). These included the British Blue (p = 0.05, OR = 1.33, [CI = 141 
1.00; 1.78]) and the Himalayan breeds (p = 0.0005, OR = 12.65, [CI 3.02; 52.92]). Several 142 
other breeds had statistically significant decreased odds of developing a skin tumour when 143 
compared to the non-pedigree cat population, including the Siamese (p<0.0001, OR = 0.63, 144 
[0.52; 0.76]), Burmese (p=0.0045, OR = 0.72, [CI 0.58; 0.90]), Birman (p=0.0002, OR = 0.35, 145 
[0.20; 0.61]) and Oriental breeds (p=0.023, OR = 0.44, [CI 0.22; 0.89]).  146 
 147 
When only malignant neoplasms are considered, no pedigree breeds had statistically significant 148 
increased odds of developing a malignant tumour when compared to the non-pedigree cat 149 
population, but several breeds had statistically significant decreased odds (figure 2); these 150 
included the Persian (p<0.0001, OR = 0.29, [CI 0.20; 0.41]), Siamese (p<0.0001, OR = 0.22, 151 
[CI 0.14; 0.36]), Burmese (p<0.0001, OR = 0.18, [CI 0.10; 0.33]), Ragdoll (p=0.0004, OR = 152 
0.28, [CI 0.14; 0.57]), British Blue (p = 0.0004, OR = 0.31, [CI 0.16; 0.59]), Birman (p = 0.056, 153 
OR = 0.28, [CI 0.078; 1.034]) and Norwegian Forest cat breeds (p = 0.012, OR = 0.20, [CI 154 
0.058; 0.71]).   155 
 156 
Age and gender 157 
Ages of affected cats ranged from under one year up to 25 years, with a median age of 11 years 158 
at the time of diagnosis. Seven cutaneous masses were from cats less than one year of age; two 159 
of these were MCTs and the remainder were non-neoplastic (two follicular hamartomas, two 160 
dermoid cysts and one cutaneous horn of feline paw-pad). There was no significant difference 161 
between the ages at which male and female animals were diagnosed with neoplastic skin 162 
tumours (p = 0.013). Malignant tumours were seen in an older population of animals (median 163 
age 12 years) compared with benign tumours (median age 11 years; p < 0.0001), and this 164 
difference was more pronounced in male cats. Male neutered cats also tended to develop benign 165 
tumours at an earlier age than female neutered cats (p = 0.0128), but no significant difference 166 
in age was seen between the genders when developing malignant tumours, nor with benign 167 
tumours arising in male entire and female entire cats.  168 
 169 
Diagnosis 170 
The ten most common skin tumour types accounted for 80.7% (7,300 out of 9,047 masses) of 171 
all the neoplastic skin masses in this study, both benign and malignant. In order of descending 172 
prevalence these were: basal cell tumours (2,189; 22.6%), fibrosarcomas (1,766; 19.5%), 173 
squamous cell carcinoma (SCC; 1,031; 11.4%), mast cell tumour (MCT; 618; 6.8%), lipoma 174 
(516; 5.7%), haemangiosarcoma (404; 4.5%), apocrine cystadenoma (269; 3.0%), 175 
undifferentiated carcinomas (255; 2.8%), basal cell carcinoma (252; 2.8%) and ceruminous 176 
gland tumours (183; 2.0%) arising within the ear canals (table 2). The gender and age 177 
distribution of affected cats with these ten most commonly occurring neoplasms are 178 
summarised in table 2 and figure 3.  179 
 180 
Basal cell tumours 181 
Basal cell tumours were the most common skin tumour in this study, accounting for 22.6% of 182 
all neoplastic skin masses (2,189 cases out of 9,047). Within this category, the majority were 183 
sub-classified as apocrine ductular adenomas (648 cases; 29.6% of all basal cell tumours) and 184 
the second most common sub-classification was trichoblastoma (610 cases; 27.9% of all basal 185 
cell tumours). If these two most common forms of basal cell tumour had been categorised as 186 
separate, distinct entities they would have ranked as the third most common skin tumour in the 187 
case of apocrine ductular adenomas, and the fifth most common in the case of trichoblastomas, 188 
just above and below MCTs respectively. The remainder of basal cell tumours in the database 189 
were either not further sub-classified (521 cases; 23.8%), or diagnosed as undifferentiated (315 190 
cases; 14.4%), or as differentiating to apocrine glands (48 cases; 2.2%), squamous cells (19 191 
cases; 0.9%), sebaceous glands (15 cases; 0.7%) or with multiple differentiation (11 cases; 192 
0.5%).  193 
 194 
The Persian (p = 0.0002, OR = 1.84, [CI = 1.33; 2.54]), British Blue (p = 0.041, OR = 1.85, 195 
[CI = 1.03; 3.34]) and Norwegian Forest cat (p = 0.0011, OR = 4.98, [CI = 1.89; 13.11]) breeds 196 
had statistically significant increased odds of having basal cell tumours compared with the non-197 
pedigree population, while the Siamese breed (p = 0.030, OR = 0.55, [CI = 0.32; 0.94]) had 198 
significantly decreased odds. The median age of cats developing basal cell tumours was 11 199 
years (ranging from one to 21 years) at the time of diagnosis (table 2), and no gender 200 
predisposition was detected.  201 
  202 
Fibrosarcoma 203 
Fibrosarcoma was the second most commonly diagnosed neoplastic skin tumour (19.5%; 1,766 204 
cases out of 9,047). The Chinchilla breed (p = 0.040, OR = 4.27, [CI 1.07; 17.08]) had 205 
statistically significant increased odds of developing fibrosarcoma compared with the non-206 
pedigree population, although the sample size for this breed was small (n = 8). The Persian (p 207 
< 0.0001, OR = 0.24, [CI 0.12; 0.47]), Siamese (p = 0.0003, OR = 0.16, [CI 0.059; 0.43]), 208 
Burmese (p = 0.0021, OR = 0.16, [CI 0.052; 0.52]) and British Blue breeds had statistically 209 
significant decreased odds of developing fibrosarcoma compared to the non-pedigree 210 
population. The median age of cats diagnosed with fibrosarcoma was also 11 years (ranging 211 
from one to 25 years; table 2), and no gender predisposition was found.   212 
 213 
Squamous cell carcinoma (SCC) 214 
SCC was the third most commonly diagnosed neoplastic skin tumour in this study (11.4%, 215 
1031 cases out of 9,047). Of these cases, 556 (53.9%) affected male cats, whether entire or 216 
neutered; male cats were at a 1.54 greater odds of developing SCC than females (p = 0.0012). 217 
Three breeds had statistically significant decreased odds of developing SCC compared to the 218 
non-pedigree cat population, including the Persian (p = 0.0055, OR = 0.3409, [CI 0.16; 0.73]), 219 
the Siamese (p = 0.0093, OR = 0.22, [CI 0.069; 0.69]) and the Burmese (p = 0.042, OR = 0.30, 220 
[CI 0.095; 0.96]). The median age of cats diagnosed with SCC was 12 years (ranging from one 221 
to 21 years; table 2).    222 
 223 
Mast cell tumours (MCT) 224 
MCT was the fourth most common neoplastic skin tumour in this study (6.8%, 618 cases out 225 
of 9,047), and included both the mastocytic and histocytic forms. Several breeds had 226 
statistically significant increased odds of developing MCT compared to the non-pedigree cat 227 
population, including the Siamese (p < 0.0001, OR = 5.3734, [CI 3.4695; 8.3223]), the 228 
Burmese (p = 0.0013, OR = 2.7702, [CI 1.491; 5.1466]), the Maine Coon (p = 0.0495, OR = 229 
1.9425, [CI 1.0015; 3.7677]) and the Ragdoll (p < 0.0001, OR = 7.4333, [CI 3.9172; 14.1053]). 230 
The Oriental (p = 0.0412, OR = 5.3095, [CI 1.069; 26.3717]), the Russian Blue (p = 0.0077, 231 
OR = 4.551, [CI 1.4947; 13.8752]) and the Havana breeds (p = 0.0047, OR = 31.8569, [CI 232 
2.8838; 351.9177]) also had statistically significant increased odds of developing MCT 233 
compared with the non-pedigree population, although the sample sizes for these breed were 234 
very small (n = 2, n = 4 and n = 2 respectively). The median age of cats diagnosed with MCTs 235 
was ten years (ranging from under one year to 20 years; table 2). 236 
 237 
Discussion 238 
Neoplasia, arising at any anatomical location, is the fourth most common cause of death for 239 
cats presenting to primary care veterinary practices within England according to a recent 240 
study,6 accounting for up to one quarter of deaths in the older cat population. Several studies 241 
have found that the skin and subcutis are the most common locations for tumours in cats,1,2 242 
with the proportion varying from 29.6% to 41.5% of all tumours arising within these tissues. 243 
Furthermore, a significant number of these tumours are malignant; the current study found that 244 
52.7% of skin tumours in cats were histologically malignant, and another recent Swiss study3 245 
found 76.1% were malignant. The difference in the proportion of malignant skin tumours 246 
between these two studies may in part be due to the differences in the two study populations; 247 
the current study utilises data from a commercial diagnostic laboratory covering the years 2006 248 
to 2011 and for who primary care veterinary practices comprise the vast majority of clients, 249 
while the former study comprises data from two university-based diagnostic laboratories as 250 
well as a private laboratory and gathered over a time span of over 40 years.   251 
  252 
In the current study, the ten most common skin tumours accounted for 80.7% of all cutaneous 253 
neoplasms, despite the large number of different diagnoses given for masses arising at this site 254 
(89 in total). Both in this study and in three other large studies2,3,4 looking at the prevalence of 255 
different skin tumours in cats, the four most commonly diagnosed tumours are very consistent, 256 
despite the differences in geographical location and time periods covered by the studies. These 257 
four skin tumours are basal cell tumours, mast cell tumours, fibrosarcomas and squamous cell 258 
carcinomas, although the precise order of prevalence varies depending on the particular study. 259 
These four most common diagnoses account for 60.3% all cutaneous tumours in UK cats in the 260 
present study, while in an earlier UK-based study4 these accounted for 65.3%, in an American-261 
based study2 they accounted for 77.1% and in the recent Swiss study3 it was 71.5%.   262 
  263 
When all tumours are considered (both benign and malignant), two breeds have statistically 264 
significant increased odds of developing cutaneous neoplasia when compared to the non-265 
pedigree cat population, namely the British Blue and the Himalayan breeds, while four breeds 266 
have decreased odds, including the Persian, Burmese, Birman and Oriental breeds. When only 267 
malignant tumours are included, no breed has statistically significant increased odds of 268 
developing neoplasia compared to the non-pedigree cat population but several have decreased 269 
odds, including the Persian, Siamese, Burmese, Ragdoll, British Blue, Birman and Norwegian 270 
Forest cat breeds. The recent Swiss study3 found that the European shorthair cat (the most 271 
common breed in that study) had the highest odds of developing a tumour in the skin or 272 
subcutis, while several other pedigree breeds had significantly lower odds ratios, overall in 273 
agreement with the present study. Studies looking for breed predispositions to various tumours 274 
in cats are always hampered to some degree by the predominance of non-pedigree cats, with 275 
far fewer representatives of some pedigree breeds being present within the feline population as 276 
a whole.    277 
 278 
The most commonly diagnosed tumour arising with the skin of cats in this study was basal cell 279 
tumour, comprising 22.6% of the total. This was also the most commonly diagnosed tumour in 280 
the previous American-based study2 (26.1%), whilst basal cell tumours ranked second most 281 
common in the Swiss study3 (14.4%) and third in the earlier UK-based study4 (14.8%). Another 282 
study7 looking at 124 feline basal cell tumours found they comprised 10.9% of all feline skin 283 
neoplasms. However, basal cell tumours are a rather heterogonous group of neoplasms, 284 
encompassing several distinct types of tumour including apocrine ductular adenomas and 285 
trichoblastomas (both of which themselves have several different histological sub-types). Both 286 
apocrine ductular adenomas and trichoblastomas appear to be common feline skin tumours in 287 
their own rights, but inconsistencies in the classification of basal cell tumours makes their true 288 
incidence in this and in other studies difficult to determine. Longhaired cats were previously 289 
reported to be predisposed to developing basal cell tumours,7 while in this study the Persian, 290 
British Blue and Norwegian Forest cat breeds were found to have significantly increased odds 291 
of developing these tumours and the Siamese breed had decreased odds. No gender 292 
predisposition was noted, similar to previous studies.2,7 293 
   294 
Fibrosarcomas were found to be the second most common skin neoplasm in this study (19.5%), 295 
and were the most common skin tumour in both previous European studies (25.4%4, 38.7%3) 296 
but fourth in the American study.2 In the present study, this category would undoubtedly 297 
include a proportion of feline injection-site sarcomas (FISS) with the histological phenotype 298 
of a fibrosarcoma, however the incidence of FISS in the UK and the US is thought to be 299 
relatively low.8 In this study only one breed – the Chinchilla – was found to have significantly 300 
increased odds of developing fibrosarcoma compared to the non-pedigree cat population, 301 
although the sample size for this breed is very small. Several breeds, including the Persian, 302 
Siamese, Burmese and British Blue breeds had significantly lower odds of developing 303 
fibrosarcoma compared to non-pedigree cats.  304 
  305 
Squamous cell carcinoma (SCC) was the third most common neoplastic skin tumour in this 306 
study (11.4%), and was also the third most common tumour in the American2 (15.2%) and 307 
Swiss studies3 (11.7%). SCC ranked second most common in the earlier UK-based study4 308 
(17.4%); the prevalence of SCC appears relatively consistent despite the different geographical 309 
locations of these studies. Both geography and skin pigmentation would be expected to 310 
influence the prevalence of SCC in different feline populations due to the relationship between 311 
SCC development and exposure to solar radiation. For example, breeds which typically have 312 
darker pigmentation of ear pinnae, eyelids and nasal planum (such as the Siamese) have 313 
previously been found to be at decreased risk of developing SCC,2,3 and the current study also 314 
supports this finding. The Burmese and Persian breeds also had a decreased risk of developing 315 
SCC compared to the non-pedigree cat population in this study; unfortunately coat colour is 316 
rarely recorded in these cases, making it impossible to determine if there is any correlation 317 
between the degree of pigmentation and the likelihood of tumour development. Male cats 318 
(neutered or entire) were found to have significantly higher odds of developing SCC than 319 
females in this study, a finding not previously reported.2 320 
  321 
Mast cell tumours (MCT) were the fourth most common skin tumour in this study, accounting 322 
for 6.8% of all feline skin neoplasia, comparable with the two previous European studies; 323 
MCTs were also the fourth most common tumour in the earlier UK-based study4 (7.7%), and 324 
were fifth most common in the Swiss study (6.7%).3 In contrast, MCTs were the second most 325 
common skin tumour in the American study,2 accounting for 21.1% of all skin neoplasia. 326 
Several breeds have previously been reported to be predisposed to developing MCTs, including 327 
the Siamese,2,9 Burmese, Russian Blue and Ragdoll breeds.9 The present study confirms these 328 
particular breed predispositions, and in addition the Maine Coon, Oriental and Havana breeds 329 
also appear to have an increased risk of developing MCTs. The two neoplastic masses arising 330 
in cats less than one year of age were also both MCTs, similar to previous studies describing 331 
MCTs arising in very young cats.10 The MCTs diagnosed in the cats in this study included both 332 
the mastocytic and histiocytic forms, as detailed in a previous study.9    333 
 334 
Conclusions 335 
In summary, this large, UK-based retrospective study of feline cutaneous tumours supports the 336 
findings of previous studies, both American- and European-based, in that the four most 337 
common skin tumours in cats are basal cell tumours, fibrosarcoma, SCC and MCTs, although 338 
there are interesting differences in the prevalence of these different tumours between the 339 
studies. Despite the large number of different diagnoses in this study, a relatively small number 340 
of tumour types accounts for the majority of skin masses in occurring cats. The study also 341 
confirms a number of apparent breed predispositions, for example to developing MCTs. When 342 
considering all forms of skin neoplasia, just over half of the masses in this study were 343 
considered histologically malignant, highlighting the importance of prompt and thorough 344 
diagnostic investigation of cutaneous masses in cats.  345 
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Table 1. Cutaneous tumours according to embryonic origin and malignancy 393 
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Haematopoietic 642 60 702 
Melanocytic 62 107 169 
Metastatic/other n/a 381 381 
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 399 
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 409 
Table 2. The ten most common types of skin tumours from a total of 9046 submissions, 410 
with the number of affected cats, male:female ratio, median and mean age. st dev = 411 
standard deviation 412 
 413 
 Neoplasm Number of 
cases (%) 
Male:female 
ratio 
Median age 
(range) 
Mean age     
(st dev) 
1 Basal cell tumour 2189 (22.6) 0.98 11 (1-21) 11.0 (3.32) 
2 Fibrosarcoma 1766 (19.5) 0.96 11 (1-25) 11.0 (3.37) 
3 Squamous cell carcinoma 1031 (11.4) 1.24 12 (1-21) 12.2 (3.30) 
4 Mast cell tumour 618 (6.8) 1.19 10 (<1-20) 9.9 (4.00) 
5 Lipoma 516 (5.7) 1.15 10 (1-18) 9.6 (3.24) 
6 Haemangiosarcoma 404 (4.5) 1.17 10.5 (1-20) 10.5 (3.59) 
7 Apocrine cystadenoma 269 (3.0) 0.88 12 (2-19) 12.0 (2.93) 
8 Carcinoma, undifferentiated 255 (2.8) 0.97 10 (4-20) 12.1 (3.01) 
9 Basal cell carcinoma 252 (2.8) 1.17 13 (2-19) 12.5 (3.14) 
10 Ceruminous gland tumour 183 (2.0) 1.02 10 (2-18) 10.3 (3.57) 
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Figure legends 423 
 424 
Figure 1. Odds ratios for all cutaneous masses in pedigree breeds compared to the non-425 
pedigree population. OR = odds ratio; 95% confidence interval, non-pedigree population OR 426 
= 1; n = 9683 427 
 428 
 429 
 430 
  431 
Figure 2. Odds ratios for malignant cutaneous neoplasms in pedigree breeds compared 432 
to the non-pedigree cat population. OR = odds ratio; 95% confidence interval, non-pedigree 433 
population OR = 1; n = 4767 434 
 435 
 436 
  437 
Figure 3. Age distribution of cats presenting with the ten most common types of skin 438 
tumour. Figure demonstrating the age distribution (median, interquartile range, minimum and 439 
maximum) of cats presenting with the ten most common types of neoplastic cutaneous tumour, 440 
starting with the most common neoplasm on the left side.  441 
 442 
 443 
